Concepedia

Author

Karína Cymes

Memorial Sloan Kettering Cancer Center

Also Known As

K Cymes, Karina Cymes, Karína Cymes

14

Publications

1.4K

Citations

11

H-Index

15

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterUniversity of Maryland, BaltimoreUniversity of BaltimoreUniversity of Massachusetts Chan Medical SchoolLong Island Jewish Medical Center
KC

About

Karína Cymes is an author at Memorial Sloan Kettering Cancer Center specializing in immunology, medicine, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

359

2

Gastroenterology

3

3

359

3

Immunology

3

3

359

4

Pathology

3

3

359

5

Autoimmunity

1

1

89

Karína Cymes

×

10

Publications

985

Citations

10

H-Index

YearCitations

Papillary Phenotype Confers Improved Survival After Resection of Hilar Cholangiocarcinoma

William R. Jarnagin, Wilbur B. Bowne, David S. Klimstra,

Annals of Surgery

2005

192

Management of primary liver sarcomas

Juürgen Weitz, David S. Klimstra, Karína Cymes,

Cancer

2007

182

Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms.

Lila Tarmin, Jing Yin, Noam Harpaz,

PubMed

1995

180

Intraductal Tubulopapillary Neoplasm of the Pancreas

Olca Baştürk, Volkan Adsay, Gokce Askan,

The American Journal of Surgical Pathology

2016

90

A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms

R. J. S. Souza, Jiao Lei, Jie Yin,

Gastroenterology

1997

89

Differential Cell Cycle–Regulatory Protein Expression in Biliary Tract Adenocarcinoma: Correlation With Anatomic Site, Pathologic Variables, and Clinical Outcome

William R. Jarnagin, David S. Klimstra, Michael Hezel,

Journal of Clinical Oncology

2006

78

Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms.

Jun-Yi Lei, Tong Zou, Ying Shi,

PubMed

1996

66

Immunophenotypic Characterization of Anal Gland Carcinoma: Loss of p63 and Cytokeratin 5/6

Mikhail Lisovsky, Keyur Patel, Karína Cymes,

Archives of Pathology & Laboratory Medicine

2007

47

Immunophenotypic characterization of anal gland carcinoma: loss of p63 and cytokeratin 5/6.

Mikhail Lisovsky, Keyur Patel, Karína Cymes,

PubMed

2007

32

Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.

Rhonda F. Souza, Laure Garrigue‐Antar, Jiao Lei,

PubMed

1996

29

Page 1